Answer
Patients with Down syndrome may have a higher risk of seizures with blinatumomab (Blincyto), so seizure prophylaxis should be considered before treatment begins.
Sources for this answer
- BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusionAmgen Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 26Document updated
Sources checked